EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudie

Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study

Hira Mian, Hsien Seow, Gregory R Pond, Anastasia Gayowsky, Ronan Foley, Amaris Balistky, Mohammed Ebraheem, Christopher Cipkar, Hyra Sapru, Ghulam Rehman Mohyuddin, Samer Al Hadidi, Alissa Visram

Clinical Lymphoma Myeloma and Leukemia · 2024

DOI: 10.1016/j.clml.2024.02.006 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024. Verfasst von Hira Mian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, McMaster University, 699 Concession Street, Hamilton, Ontario L8V 5C2, Canada. Electronic address: hira.mian@medportal.ca. Hauptthemen laut MEDLINE: Multiple Myeloma, Patient Acceptance of Health Care. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aims to describe the treatment patterns, outcomes, health care utilization and symptom burden of triple class exposed (TCE) relapsed/refractory patents with multiple myeloma (MM) receiving a subsequent line of treatment (LOT). METHODS: This is a retrospective observational cohort study using administrative databases in Ontario, Canada. Outcomes were captured for TCE patients receiving a subsequent LOT and included: treatment regimen details, time to next treatment (TTNT), overall survival (OS), health care utilization, palliative care referral, and patient reported symptoms. RESULTS: Of the 16,777 patients diagnosed with MM between 2007-2021 in Ontario, 1358 (8%) patients were classified as TCE. Among the TCE MM patients, 489 (36%) received a subsequent LOT. The two most commonly administered therapies post TCE were carfilzomib/dexamethasone (n = 111, 22%) and pomalidomide/dexamethasone(n = 95, 19%). Median TTNT was 1.7 months (95%CI 1.2-2.4 months) and median OS 12.8 months (95%CI 10.8-16.5). Healthcare utilization was high with 276 (56%) of patients evaluated in an emergency department (ED) or admitted to hospital. There was high symptom burden as reported by patients with moderate-severe impairment in well-being, fatigue, pain and drowsiness noted in greater than 25% of the cohort. Palliative care referrals rates were low with only 10% (n = 48) patients referred to palliative care. Among the patients that died during study follow up, the majority died in hospital (n = 147,44%). CONCLUSION: Our study reports one of the largest series of real-world TCE patients published and demonstrates the poor outcomes of TCE patients receiving a subsequent LOT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaPatient Acceptance of Health CareHumansMaleFemaleAgedMiddle AgedRetrospective StudiesAged, 80 and overOntarioAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesSymptom Burden

Stichwörter der Autor:innen

Burden of careHealth servicesHematologic malignanciesQuality of lifeRelapsed/Refractory

Autor:innen und Institutionen

  • Department of Oncology, McMaster University, 699 Concession Street, Hamilton, Ontario L8V 5C2, Canada. Electronic address: hira.mian@medportal.ca.
  • Department of Oncology, McMaster University, 699 Concession Street, Hamilton, Ontario L8V 5C2, Canada.
  • ICES, McMaster University, 1290 Main Street West, HSC 4N43, Hamilton, Ontario L8S 4K1, Canada.
  • Department of Medicine, University of Ottawa, 451 Smyth Rd, Ottawa, Ontario K1H 8M5, Canada.
  • Department of Medicine, University of Utah, 27 S Mario Capecchi Dr, Salt Lake City, Utah 84113, USA.
  • Department of Medicine, University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, Arkansas 72205, USA.

Zitieren

APA

Mian, H., Seow, H., Pond, G. R., Gayowsky, A., Foley, R., Balistky, A., Ebraheem, M., Cipkar, C., Sapru, H., Mohyuddin, G. R., Hadidi, S. A., & Visram, A. (2024). Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.02.006

Vancouver

Mian H, Seow H, Pond GR, Gayowsky A, Foley R, Balistky A, et al. Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study. Clinical Lymphoma Myeloma and Leukemia. 2024. doi:10.1016/j.clml.2024.02.006

BibTeX
@article{Mian2024,
  author = {Mian, Hira and Seow, Hsien and Pond, Gregory R and Gayowsky, Anastasia and Foley, Ronan and Balistky, Amaris and Ebraheem, Mohammed and Cipkar, Christopher and Sapru, Hyra and Mohyuddin, Ghulam Rehman and Hadidi, Samer Al and Visram, Alissa},
  title = {Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2024},
  doi = {10.1016/j.clml.2024.02.006}
}
Kostenlos starten →